A novel de novo TET3 loss-of-function variant in a Turkish boy presenting with neurodevelopmental delay and electrical status epilepticus during slow-wave sleep

Published:September 30, 2022DOI:



      Beck-Fahrner syndrome is caused by homozygous or heterozygous mutations in TET3 on chromosome 2p13. The general characteristics of this syndrome include behavioral abnormalities such as autistic features, attention-deficit hyperactivity disorder, learning disabilities, and epilepsy.

      Case presentation

      Six years old male patient was found to have a de novo TET3 loss-of-function variant by whole-exome sequencing (WES) analysis and was diagnosed with electrical status epilepticus during slow-wave sleep (ESES) based on clinical and electroencephalogram (EEG) characteristics. The patient had a neurodevelopmental delay from the age of 3 months and started experiencing generalized tonic–clonic seizures and regression at the age of 5 years. EEG findings were consistent with ESES, and WES analysis revealed a novel heterozygous nonsense NM_001366022.1:c.1594C > T (p.Arg532*) variant in TET3. Valproic acid and immunotherapy were administered for the first 6 months, and clobazam was administered orally in addition to oral valproic acid therapy for the next 6 months. Clinical improvement was noted regardless of EEG improvement for the first 6 months. EEG improvement was achieved with clobazam. No regression was observed following the discontinuation of immunotherapy.


      Decreased TET3 enzyme activity may be one of the new genetic etiologies of ESES.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Beck D.B.
        • Petracovici A.
        • He C.
        • Moore H.W.
        • Louie R.J.
        • Ansar M.
        • et al.
        Delineation of a human Mendelian disorder of the DNA demethylation machinery: TET3 deficiency.
        Am J Hum Genet. 2020; 106: 234-245
        • Kohli R.M.
        • Zhang Y.
        TET enzymes, TDG and the dynamics of DNA demethylation.
        Nature. 2013; 502: 472-479
        • Li T.
        • Yang D.
        • Li J.
        • Tang Y.
        • Yang J.
        • Le W.
        Critical role of Tet3 in neural progenitor cell maintenance and terminal differentiation.
        Mol Neurobiol. 2015; 51: 142-154
        • Amouroux R.
        • Nashun B.
        • Shirane K.
        • Nakagawa S.
        • Hill P.W.S.
        • D’Souza Z.
        • et al.
        De novo DNA methylation drives 5hmC accumulation in mouse zygotes.
        Nat Cell Biol. 2016; 18: 225-233
        • Ito S.
        • Shen L.i.
        • Dai Q.
        • Wu S.C.
        • Collins L.B.
        • Swenberg J.A.
        • et al.
        Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine.
        Science. 2011; 333: 1300-1303
        • Irier H.
        • Street R.C.
        • Dave R.
        • Lin L.i.
        • Cai C.
        • Davis T.H.
        • et al.
        Environmental enrichment modulates 5-hydroxymethylcytosine dynamics in hippocampus.
        Genomics. 2014; 104: 376-382
        • Patry G.
        • Lyagoubi S.
        • Tassinari C.A.
        Subclinical “electrical status epilepticus” induced by sleep in children. A clinical and electroencephalographic study of six cases.
        Arch Neurol. 1971; 24: 242-252
        • Arican P.
        • Gencpinar P.
        • Olgac Dundar N.
        • Tekgul H.
        Electrical status epilepticus during slow-wave sleep (ESES): current perspectives.
        J Pediatr Neurosci. 2021; 16: 91-96
        • Manjón J.V.
        • Coupé P.
        volBrain: An online MRI brain volumetry system.
        Front Neuroinform. 2016; 27: 30
        • Seyama R.
        • Tsuchida N.
        • Okada Y.
        • Sakata S.
        • Hamada K.
        • Azuma Y.
        • et al.
        Two families with TET3-related disorder showing neurodevelopmental delay with craniofacial dysmorphisms.
        J Hum Genet. 2022; 67: 157-164
        • Akahori H.
        • Guindon S.
        • Yoshizaki S.
        • Muto Y.
        Molecular evolution of the TET gene family in mammals.
        Int J Mol Sci. 2015; 16: 28472-28485
        • Levy M.A.
        • Beck D.B.
        • Metcalfe K.
        • Douzgou S.
        • Sithambaram S.
        • Cottrell T.
        • et al.
        Deficiency of TET3 leads to a genome-wide DNA hypermethylation episignature in human whole blood.
        NPJ Genom Med. 2021; 6
        • Santos-Cortez R.L.P.
        • Khan V.
        • Khan F.S.
        • Mughal Z.-u.-N.
        • Chakchouk I.
        • Lee K.
        • et al.
        Novel candidate genes and variants underlying autosomal recessive neurodevelopmental disorders with intellectual disability.
        Hum Genet. 2018; 137: 735-752
        • Fainberg N.
        • Harper A.
        • Tchapyjnikov D.
        • Mikati M.A.
        Response to immunotherapy in a patient with Landau-Kleffner syndrome and GRIN2A mutation.
        Epileptic Disord. 2016; 18: 97-100